Cholangiocarcinoma Cancer, HCC - Hepatocellular Carcinoma
Conditions
Brief summary
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in IRCCS Azienda Ospedaliera Universitaria Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
Detailed description
This study is non profit, observational, retrospective, prospective and single institution. The researchers will do a retrospective and prospective data collection and analyze the results. They will examine the radiological images (CT scan and RM) to assess the type and size of the cancer, track how the disease responds to treatments, identify possible complications. There are no drugs involved and all the intra arterial therapies are performed within the routine clinical-care path. * For the retrospective phase the researchers will analyze radiological image of the participants that received a intra arterial therapy from the 1st of January 2009. It's expected to enroll around 2000 participants. * For the prospective phase the researchers will enroll for 5 years eligible participants that will receive a intra arterial therapy. Participants will go through a follow up every three months for the duration of the whole study. It is expected to enroll around 1300 participants.
Interventions
None listed
Sponsors
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments: * Trans-arterial embolization (TAE), * Transarterial chemoembolization (TACE), * Transarterial radioembolization (TARE) * Drug-eluting beads chemoembolization (DEB-TACE) * Age over 18 * To give informed consent
Exclusion criteria
* shunt of gastro intestinal arteries that cannot be embolized * metastasis spread outside of the liver * liver failure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Type and size of the injury | From enrollment to the end of treatment at 9 years | Type and size of the injury |
| Radiological response to therapy | From enrollment to the end of treatment at 9 years | Radiological response to therapy |
| Post treatment complications | From enrollment to the end of treatment at 9 years | Post treatment complications |
Countries
Italy
Contacts
Primary ContactCristina Mosconi, MD
Outcome results
None listed